EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

One or two ultrasonography-guided botulinum toxin A injections in the treatment of refractory lateral epicondylalgia? A retrospective study

Pierre-Loup Tabary, Jérémy Picard, Olivier Rémy-Néris, Gwenaël Cornec

Muscles, Ligaments and Tendons Journal · 03.11.2026

DOI: 10.32098/mltj_2026_7236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscles, Ligaments and Tendons Journal, online erschienen am 03.11.2026. Verfasst von Pierre-Loup Tabary und 3 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Design

Retrospective cohort study evaluating the outcomes and safety of botulinum toxin A injections in refractory lateral epicondylalgia.

Participants

Seventy-nine patients (81 elbows) with refractory lateral epicondylalgia (persistent pain despite ≥6 months conservative treatment) treated between August 2022 and December 2023.

Interventions

All patients received an initial ultrasound-guided injection of 40 units of botulinum toxin A into the extensor carpi radialis brevis (ECRB). A second injection was offered in case of persistent symptoms, targeting the ECRB, extensor digitorum communis and/or supinator depending on standard provocative tests. Main measures: Clinical outcome was categorised as ‘poor’, ‘temporary’, ‘partial’ or ‘good’ based on self-reported pain evolution. Patients no longer requesting care were classified in the ‘good’ category. Adverse events were systematically recorded.

Results

After the first injection, 20% (16/81) had a ‘good’ outcome. Among 51 elbows receiving a second injection, 47% (24/51) reached this category, yielding an overall rate of 49% (40/81). Favourable outcome was not significantly associated with sex, age, or number of muscles injected in univariable analyses. Transient motor weakness occurred in 34% (27/79) of patients; one patient experienced a persistent deficit lasting six months with functional impairment.

Conclusions

A second ultrasound-guided botulinum toxin A injection with individually tailored muscle targeting was associated with a favourable outcome in about half of patients insufficiently relieved after the first one. Randomised controlled trials are needed to evaluate the added benefit of a tailored muscle targeting strategy and ultrasound guidance in the management of refractory lateral epicondylalgia.

Zitieren

APA

Tabary, P., Picard, J., Rémy-Néris, O., & Cornec, G. (2026). One or two ultrasonography-guided botulinum toxin A injections in the treatment of refractory lateral epicondylalgia? A retrospective study. Muscles, Ligaments and Tendons Journal. https://doi.org/10.32098/mltj_2026_7236

Vancouver

Tabary P, Picard J, Rémy-Néris O, Cornec G. One or two ultrasonography-guided botulinum toxin A injections in the treatment of refractory lateral epicondylalgia? A retrospective study. Muscles, Ligaments and Tendons Journal. 2026. doi:10.32098/mltj_2026_7236

BibTeX
@article{Tabary2026,
  author = {Tabary, Pierre-Loup and Picard, Jérémy and Rémy-Néris, Olivier and Cornec, Gwenaël},
  title = {One or two ultrasonography-guided botulinum toxin A injections in the treatment of refractory lateral epicondylalgia? A retrospective study},
  journal = {Muscles, Ligaments and Tendons Journal},
  year = {2026},
  doi = {10.32098/mltj_2026_7236}
}
Kostenlos starten →